Mast Therapeutics (MSTX)

Add to Watchlists
Create an Alert
0.56 +0.01  +1.80% AMEX Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
MSTX Price Chart
View All Performance Charts

MSTX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Mast Therapeutics is down 16.39% over the last year vs S&P 500 Total Return up 22.72%, Ohr Pharmaceutical up 94.17%, and GlycoMimetics up N/A.

Get Quote for

Portfolio Strategies Featuring MSTX

Did Mast Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

MSTX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Mast Therapeutics Inc is a biopharmaceutical company develops novel therapies for serious or life-threatening diseases with significant unmet needs.

Recent Quotes

Symbol Price Chg Chg % Market Cap
MSTX 0.56 +0.01 +1.80% 57.52M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.